Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTourmaline Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.95 | -$0.80 | -$0.88 |
| Q2 2025 | 2 | -$0.91 | -$0.91 | -$0.91 |
| Q3 2025 | 2 | -$0.96 | -$0.96 | -$0.96 |
| Q4 2025 | 2 | -$0.96 | -$0.96 | -$0.96 |
| Q1 2026 | 1 | -$1.37 | -$1.37 | -$1.37 |
| Q2 2026 | 1 | -$1.42 | -$1.42 | -$1.42 |
| Q3 2026 | 1 | -$1.48 | -$1.48 | -$1.48 |
| Q4 2026 | 1 | -$1.71 | -$1.71 | -$1.71 |
Tourmaline Bio, Inc. Earnings Date And Information
Tourmaline Bio, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.78 earnings per share for the quarter, topping analysts' consensus estimates of $-0.84 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Tourmaline Bio, Inc. has generated $-9 earnings per share over the last year ($-8.87 diluted earnings per share) and currently has a price-to-earnings ratio of -9.81. Tourmaline Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Tourmaline Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.84 | -$0.78 | 0.06 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$0.72 | -$0.68 | 0.04 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$0.68 | -$0.55 | 0.13 | $0 | |
| 03/19/2024 | Q4 2023 | -$0.75 | -$0.81 | -0.06 | $2.28 M | |
| 09/29/2023 | Q3 2023 | -$0.34 | $0 | |||
| 06/29/2023 | Q2 2023 | -$1.30 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.37 | $0 | |||
| 12/30/2022 | Q4 2022 | -$0.00 | $0 | |||
| 09/29/2022 | Q3 2022 | -$0.00 | $0 | |||
| 06/29/2022 | Q2 2022 | -$0.00 | $0 | |||
| 03/30/2022 | Q1 2022 | $0.00 | $0 | |||
| 12/29/2021 | Q4 2021 | -$3.48 | $0 | |||
| 09/28/2021 | Q3 2021 | -$3.18 | $0 | |||
| 06/29/2021 | Q2 2021 | -$4.15 | $0 | |||
| 03/30/2021 | Q1 2021 | -$2.43 | $0 | |||
| 12/30/2020 | Q4 2020 | -$9.60 | $0 | |||
| 09/29/2020 | Q3 2020 | -$9.40 | $0 | |||
| 06/29/2020 | Q2 2020 | -$7.29 | $0 | |||
| 03/30/2020 | Q1 2020 | -$1.42 | $0 |
Tourmaline Bio, Inc. Earnings: FAQ's
When is Tourmaline Bio, Inc.'s earnings date?
Tourmaline Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
Did Tourmaline Bio, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Tourmaline Bio, Inc. (:TRML) reported $-0.78 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.84 by $0.06.
How can I listen to Tourmaline Bio, Inc.'s earnings conference
call?
The conference call for Tourmaline Bio, Inc.'s latest earnings report can be listened to online.
How can I read Tourmaline Bio, Inc.'s conference call transcript?
The conference call transcript for Tourmaline Bio, Inc.'s latest earnings report can be read online.
How much profit does Tourmaline Bio, Inc. generate each year?
Tourmaline Bio, Inc. (:TRML) has a recorded net income of $0. Tourmaline Bio, Inc. has generated $-8.87 earnings per share over the last four quarters.
What is Tourmaline Bio, Inc.'s price-to-earnings ratio?
Tourmaline Bio, Inc. (:TRML) has a price-to-earnings ratio of -9.81 and price/earnings-to-growth ratio is 0.53.